RD-Biotech supplier of murine monoclonal antibodies D1-25 and 1112-1
RD-Biotech supplier of murine monoclonal antibodies D1-25 and 1112-1, for the quantification of rabies virus by ELISA.
Signature of license agreements with Institut Pasteur - France and with Winstar Institute - USA: RDBiotech becomes the supplier of the clones D1-25 and 1112-1 and now offers the antibody pair for ELISA detection of rabies virus glycoprotein G:
- Monoclonal antibody 1112-1: Capture antibody
- Monoclonal antibody D1-25: Detection antibody, biotinylated
Contact us for more information!
Partnership agreement with Luminex Corporation
RD-Biotech is pleased to announce the signature of a partnership agreement with Luminex Corporation.
NOW AVAILABLE: A range of custom services with Luminex xMAP® technology!
From providing labeled analytes to assay development, we can help you to get your Multiplexed assay-faster.
Contact us for more information!
DNA plasmid production, High Quality Grade (“GMP like”)
RD-Biotech is now a major player in the DNA plasmid production, High Quality Grade (“GMP like”) providing raw material for therapeutic purposes and an essential tool for mRNA vaccine development!
Contact us for more information!
Join us at RD-Biotech!
Are you a researcher, engineer or technician in the field of biotechnology and wish to join a dynamic developing company?
Contact RD-Biotech send your CV and cover letter to: info@rd-biotech.com
PACKAGE OFFER, from vector design to the production of your recombinant antibodies or proteins!
- Design, optimization, vector cloning
- Choice between different systems of expression: E. coli, CHO cells, HEK cells, cell free system (in vitro)
- Expression and purification, quality controls
A team of experts at your disposal to quality service in a very short time and at the best price. Contact us for more information!
Our sister company, Diaclone, is now part of the Medix Biochemica group
Biotech Investissement (www.mabexperts.com) separates from its subsidiary Diaclone by selling it to Medix Biochemica.
The arrival of Diaclone in the Medix group will allow it to access new international markets, and therefore to continue its growth in the In Vitro Diagnostics (IVD) market.
Our group will now focus on the development of biomanufacturing services for plasmid DNAs, antibodies and recombinant proteins with in particular the upcoming construction of a new DNA production unit, GMP grade (BPF) at RD-BIOTECH.
Link to the press release: Biotech Investissement communication
Contact us for more information!
Discover and test our FastELISA Kits
Discover and test our FastELISA Kits: The quickest ELISA Kits on the market!
Easy one-step process – Results in less than 30 minutes – Colored pipetting tracking – Ready-to-use reagents
Applications:
- Ig quantification (Screening of therapeutic antibodies, Production monitoring, Selection of ‘goodproducer’ clones, Pharmacokinetics, Validation of vectors, …)
- Ig isotyping
- Cell contaminant detection
And new kits coming soon!
Contact us for more information!
BioNTech’s COVID-19 vaccine
The entire RD-Biotech team is proud to have participated in the development of BioNTech’s mRNA COVID-19 vaccine and thank them for putting their trust in our company!
To the: BioNTech press release
RD-Biotech produce the monoclonal antibodies used in the IVD RAPID TEST COVID-19 Ag Respi-Strip!
RD-Biotech is proud to produce the monoclonal antibodies used in the IVD RAPID TEST COVID-19 Ag Respi-Strip developed by Coris BioConcept!
RD-Biotech, a major French actor in the production of monoclonal antibodies and recombinant proteins, is proud to be a qualified Partner of the Belgian company Coris BioConcept regarding the development of the new IVD rapid test COVID-19 Ag Respi-Strip now manufactured by Coris BioConcept.
Contact us for more information!